EE265 Cost-Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients With Treatment Failure After C5 Inhibitor Therapy: An Analysis From the Brazilian Public Healthcare System Perspective
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.649
https://www.valueinhealthjournal.com/article/S1098-3015(25)03206-1/fulltext
Title :
EE265 Cost-Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients With Treatment Failure After C5 Inhibitor Therapy: An Analysis From the Brazilian Public Healthcare System Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03206-1&doi=10.1016/j.jval.2025.09.649
First page :
Section Title :
Open access? :
No
Section Order :
10233